Product Information

SM CHEST CONGEST RLF DM CAPLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0796 per EA under NDC 49348072809. Its NADAC has been published 629 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the Dextromethorphan Hydrobromide / Guaifenesin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

SM CHEST CONGEST RLF DM CAPLET

Dextromethorphan Hydrobromide / Guaifenesin
$0.0796per EA
High Outlier
OTC

Strength

20; 400 mg/1; mg/1

NDC

49348072809

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

3/18/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

8/1/2012

Pharmacological Classes

Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists

Price Statistics

The NADAC for SM CHEST CONGEST RLF DM CAPLET has been published 629 times since Nov 28, 2013, and over the history we have for it it has risen 10.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0796 per EA
All-time high$0.0877 (Aug 12, 2020)
All-time low$0.0691 (Oct 22, 2014)
52-week high$0.0798
52-week low$0.0771
Median price$0.0780
Average price$0.0777
Largest weekly change+13.7% (Jun 22, 2022)
Weeks tracked629
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+1.3%

1Y

+3.2%

3Y

+4.0%

5Y

+4.7%

All

+10.8%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SM CHEST CONGEST RLF DM CAPLET?

The current National Average Drug Acquisition Cost (NADAC) for SM CHEST CONGEST RLF DM CAPLET, manufactured by Strategic Sourcing Services LLC, is $0.0796 per EA (NDC 49348072809), effective Apr 1, 2026.

How has the price of SM CHEST CONGEST RLF DM CAPLET changed over time?

Over the history we have for it, the NADAC for SM CHEST CONGEST RLF DM CAPLET has risen 10.8%. It has been tracked across 629 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for SM CHEST CONGEST RLF DM CAPLET?

Since Nov 28, 2013, the NADAC for SM CHEST CONGEST RLF DM CAPLET has ranged from a low of $0.0691 (Oct 22, 2014) to a high of $0.0877 (Aug 12, 2020), with a median of $0.0780 per EA.

Are there cheaper alternatives to SM CHEST CONGEST RLF DM CAPLET?

Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QC MUCUS RELIEF DM TABLET, is $0.0766 per EA — about 4% below SM CHEST CONGEST RLF DM CAPLET.

Who manufactures SM CHEST CONGEST RLF DM CAPLET?

SM CHEST CONGEST RLF DM CAPLET (NDC 49348072809) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.